Christian Streck to Genetic Therapy
This is a "connection" page, showing publications Christian Streck has written about Genetic Therapy.
Connection Strength
0.614
-
Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta. Cancer Gene Ther. 2006 Jan 01; 13(1):99-106.
Score: 0.226
-
Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth. J Pediatr Surg. 2005 Jan; 40(1):236-43.
Score: 0.211
-
Interferon-mediated anti-angiogenic therapy for neuroblastoma. Cancer Lett. 2005 Oct 18; 228(1-2):163-70.
Score: 0.056
-
Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models. Clin Cancer Res. 2005 Aug 15; 11(16):6020-9.
Score: 0.055
-
Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta. Surgery. 2004 Aug; 136(2):183-9.
Score: 0.051
-
Continuous delivery of human type I interferons (alpha/beta) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model. Blood. 2007 Feb 01; 109(3):1244-7.
Score: 0.015